Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Identification of novel targeted therapies for BAP1 mutated tumors

Mohamed H Abdel-Rahman; Leili Shahriyari; James B Massengill; Kari Kendra; Thomas Olencki; Frederick H Davidorf; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4958. doi:

ARVO Annual Meeting Abstract June 2017

Ocular side effects of novel and traditional chemotherapeutic agents

Anne Kunkler; Kari Kendra; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5166. doi:

ARVO Annual Meeting Abstract September 2016

Chemotherapy with biological agents and ocular side effects

Dimosthenis Mantopoulos; Elaine Michele Binkley; Anne L Kunkler; Kari Kendra; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):298. doi:

ARVO Annual Meeting Abstract September 2016

Ocular side effects of traditional chemotherapeutics and small molecule inhibitors

Anne L Kunkler; Elaine Michele Binkley; Dimosthenis Mantopoulos; Kari Kendra; Colleen M Cebulla

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):299. doi:

Advertisement